聯影醫療(688271.SH):擬2848.72萬元投資聯影智能
格隆匯12月20日丨聯影醫療(688271.SH)公佈,公司使用2,848.72萬元自有資金投資聯影智能,公司董事會授權管理層辦理包括但不限於合同簽署、資金撥付等相關事宜。本次交易,聯影集團擬以自有資金取得聯影智能增資後2.0000%的股權,上海聯和擬以自有資金取得聯影智能增資後1.7901%的股權,鑑於聯影集團為公司控股股東,上海聯和為直接持有公司5%以上股份的法人,聯影智能受公司控股股東聯影集團控制,根據《上海證券交易所科創板股票上市規則(2024年4月修訂)》的規定,聯影集團、上海聯和及聯影智能為公司關聯方。故本次交易構成向關聯方增資暨與關聯方共同投資的關聯交易,不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.